Videos de Experimentos Relacionados
Preparación de crioprecipitado en preparación.
Lancet (London, England)
|January 20, 1979
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Human platelets express endothelial protein C receptor, which can be utilized to enhance localization of factor VIIa activity.
Journal of thrombosis and haemostasis : JTH·2018
Same author
A comparative analysis of heterogeneity in commercially available recombinant factor VIII products.
Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same author
Chromogenic analysis of FIX activity in haemophilia B patients treated with nonacog beta pegol.
Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author
The pharmacokinetics and pharmacodynamics of single-dose and multiple-dose recombinant activated factor VII in patients with haemophilia A or B.
Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author
Qualification of a select one-stage activated partial thromboplastin time-based clotting assay and two chromogenic assays for the post-administration monitoring of nonacog beta pegol.
Journal of thrombosis and haemostasis : JTH·2017
Same author
Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits: a two-centre study.
Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026